Labcorp Holdings LH Diagnostics — Other Cost and Expense, Operating

Other segment segments

Similar metrics at other companies

RVTYDiagnostics — Restructuring and Other Costs (Income)

$7.55M+5,496%

DHRDiagnostics — Segment Reporting, Other Segment Item, Amount

$1.59B+0.6%

SOTKOperating — Other Cost

$77K+35.1%

RVTYDiagnostics — Segment operating income

$76.12M+2.8%

RVTYDiagnostics — Segment Selling, general and administrative expenses

$90.19M+0.3%

CLVTLife Sciences & Healthcare — Other Cost and Expense, Operating

$3M+20.0%

Questions, answered.

What is Labcorp Holdings's diagnostics — other cost and expense, operating?

Labcorp Holdings (LH) reported diagnostics — other cost and expense, operating of $438M in Q1 2026.

How has Labcorp Holdings's diagnostics — other cost and expense, operating changed year-over-year?

Labcorp Holdings's diagnostics — other cost and expense, operating increased by 1.8% year-over-year, from $430.2M to $438M.

What is the long-term trend for Labcorp Holdings's diagnostics — other cost and expense, operating?

Over 2 years (2022 to 2025), Labcorp Holdings's diagnostics — other cost and expense, operating has grown at a 14.1% compound annual growth rate (CAGR), from $1.38B to $1.79B.

What does diagnostics — other cost and expense, operating mean?

This captures all remaining operating costs for the diagnostics segment not categorized as labor, supplies, or depreciation, including facility rent, utilities, IT infrastructure, and administrative overhead. It provides insight into the segment's fixed cost structure and general operational support expenses.